Triple-Negative Breast Cancer (TNBC) Active Not Recruiting Phase 2 Trials for Paclitaxel (DB01229)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01525966Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast CancerTreatment
NCT01463072Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Older Patients With Locally Advanced or Metastatic Breast CancerTreatment
NCT01818063Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast CancerTreatment
NCT02413320Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast CancerTreatment